• Non ci sono risultati.

Part IV: Epidermal and Dermal Lesions, Eczematous Lesions, and Atrophies

N/A
N/A
Protected

Academic year: 2022

Condividi "Part IV: Epidermal and Dermal Lesions, Eczematous Lesions, and Atrophies"

Copied!
1
0
0

Testo completo

(1)

Part IV: Epidermal and Dermal Lesions, Eczematous Lesions, and Atrophies

IMPORTANT ABBREVIATIONS USED IN THIS PART:

AD Atopic dermatitis ANA Antinuclear antibody

DLE Discoid lupus erythematosus

NSAID Nonsteroidal anti-inflammatory drugs OTC Over-the-counter

RIF Rapid immunofluorescence test

SCLE Subacute cutaneous lupus erythematosus SLE Systemic lupus erythematosus

SPF Sun protection

173

Riferimenti

Documenti correlati

Granular deposits of C3 along the dermoepidermal junc- tion of a chronic dis- coid lupus erythema- tosus lesion (a similar pattern is often seen in a false-positive lupus band

Laboratory tests associated with the development of SLE in patients with DLE include severe leukopenia, unexplained anemia, false-posi- tive serologic tests for syphilis,

Several recent reviews summarize therapeutic measures of CLE or cutaneous manifestation in the context of systemic LE (SLE) from various aspects (Abu-Shakra and Buskila 2002,

Jewell ML, McCauliffe DP (2000) Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J Am Acad

In summary, the complex disease LE was first recognized and evaluated by its vis- ible cutaneous manifestations before the analysis and study of its systemic manifes-

In the evaluation of several patients with both anti-U1RNP and anti-Ro/SSA anti- body-associated neonatal lupus, the author detected the presence of erythema multi-

Cardinali C, Caproni M, Fabbri P (1999) The utility of the lupus band test on sun-protected non-lesional skin for the diagnosis of systemic lupus erythematosus.. Clin Exp Rheumatol

Black DR, Hornung CA, Schneider PD, Callen JP (2002) Frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus.. Arch